It is generally agreed that survival in the midlethal radiation dose range depends principally on hemopoietic recovery. Administration of endotoxin as a single injection either before or shortly after irradiation in the mouse hastens recovery of granulocytes, erythrocytes, platelets, and lymphocytes (1, 2), increases resistance to infection (3), and reduces mortality (4). In contrast, multiple injections given before irradiation cause no advance in leukocyte recovery or increase in survival (4, 5), even though such injections in nonirradiated mice cause greater increases in spleen weight and resistance to bacterial challenge than a single injection. Till and McCulloch have observed that nodules seen in the spleen 10 days after irradiation are erythroid, granulocytic, megakaryocytic, or mixed (6) and that their number is related to radiation dose and survival (7, 8). The present experiments show that a single injection of endotoxin increases splenic nodules as well as granulocyte count and survival. In contrast, the multiple injections increase the number of splenic nodules (though to a lesser extent) without promoting marrow recovery or survival.
[1]
J. Cornfield,et al.
Estimation of radiation dose-reduction factor for beta-mercaptoethylamine by endogenous spleen colony counts.
,
1966,
Radiation research.
[2]
J. Till,et al.
A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.
,
1961,
Radiation research.
[3]
J. Cornfield,et al.
Patterns of hemopoietic recovery in irradiated mice.
,
1959,
Blood.
[4]
W. W. Smith,et al.
Resistance to experimental infection and mobilization of granulocytes in irradiated mice treated with bacterial endotoxin.
,
1958,
American Journal of Physiology.
[5]
W. W. Smith,et al.
Increased survival in irradiated animals treated with bacterial endotoxins.
,
1957,
The American journal of physiology.
[6]
J. Till,et al.
Early repair processes in marrow cells irradiated and proliferating in vivo.
,
1963,
Radiation research.